Cargando…
The prospect of orally administered monoclonal secretory IgA (SIgA) antibodies to prevent enteric bacterial infections
Eliminating diarrheal diseases as a leading cause of childhood morbidity and mortality in low- and middle-income countries (LMICs) will require multiple intervention strategies. In this review, we spotlight a series of preclinical studies investigating the potential of orally administered monoclonal...
Autores principales: | Richards, Angelene, Baranova, Danielle, Mantis, Nicholas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103515/ https://www.ncbi.nlm.nih.gov/pubmed/34491878 http://dx.doi.org/10.1080/21645515.2021.1964317 |
Ejemplares similares
-
Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases
por: Tharmalingam, Tharmala, et al.
Publicado: (2021) -
Inhaled antibodies: Quality and performance considerations
por: Hickey, Anthony James, et al.
Publicado: (2021) -
The biophysical principles underpinning muco-trapping functions of antibodies
por: Schaefer, Alison, et al.
Publicado: (2021) -
Emerging antibody-based products for infectious diseases: Planning for metric ton manufacturing
por: Whaley, Kevin J, et al.
Publicado: (2021) -
Antibody-dependent passive protection of mucosal surfaces
por: Mestecky, Jiri
Publicado: (2021)